The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges

Prostate cancer (PCa) is the most common cause of malignancy in males and the second leading cause of cancer mortality in United States. Current treatments for PCa include surgery, radiotherapy, and androgen-deprivation therapy. Eventually, PCa relapses to an advanced castration-resistant PCa (CRPC)...

Full description

Bibliographic Details
Main Authors: Eun-Jin Yun, U-Ging Lo, Jer-Tsong Hsieh
Format: Article
Language:English
Published: Elsevier 2016-10-01
Series:Asian Journal of Urology
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388216300674